Dear All
From the trail below, shell formula has changed and affect the products that were already register in Thailand.
ENAT100, 200 and 400 which were mentioned below need variation submission to Thai-FDA.
As checked, the condition of the change complies to minor variation as per ASEAN Variation guideline.
Conditions.
1. Dissolution profile of the proposed product is comparable to that of the current approved product.
2. The product release and end-shelf-life specifications of the drug product remain unchanged except for the weight and/or size.
Documents required.
1. Comparative dissolution profile data of at lease 1 pilot/production batch of the drug product between the currently approved and proposed composition.
2. Revised released and shelf-life specification of the drug product.
3. A declaration that the change does not interfere with the drug product release and shelf-life specification test method.
4. Comparative tabulated format of current and proposed product and batch manufacturing formula.
5. Stability data as per ASEAN Guideline on stability Study of Drug Product and report.
Thank you, Best regards,